{"slideshow_credits": null, "snippet": "The court&#8217;s decision could delay competitors&#8217; generic versions of Copaxone, made by Teva Pharmaceutical Industries.", "abstract": "Supreme Court agrees to hear Teva Pharmaceutical Industries' appeal of lower-court ruling that invalidated a patent that would have protected its popular and lucrative multiple sclerosis drug, Copaxone, until September 2015; court\u2019s decision could delay competitors\u2019 generic versions of the drug.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/04/01/business/supreme-court-to-hear-appeal-of-multiple-sclerosis-drug-case.html", "lead_paragraph": "The court&#8217;s decision could delay competitors&#8217; generic versions of Copaxone, made by Teva Pharmaceutical Industries.", "headline": {"main": "Supreme Court to Hear Appeal of Generic Drug Case", "print_headline": "Supreme Court to Hear Appeal of Generic Drug Case"}, "_id": "5339a79b38f0d844a7d52564", "word_count": "983", "multimedia": [{"height": 126, "url": "images/2014/04/01/business/Teva/Teva-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/04/01/business/Teva/Teva-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 790, "url": "images/2014/04/01/business/Teva/Teva-articleLarge.jpg", "legacy": {"xlarge": "images/2014/04/01/business/Teva/Teva-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "790"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/04/01/business/Teva/Teva-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/04/01/business/Teva/Teva-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-04-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Multiple Sclerosis", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Supreme Court (US)", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}